Microfluidic
devices market is gaining significant importance due to growing R&D
investment in life sciences, pharmaceuticals, and increasing point of care
testing demand. The global market for microfluidic devices is expected to grow
at a CAGR of 23.0% during the period 2015 to 2020 to reach $6,471 million by
2020. The factors driving the growth of microfluidic devices market are increase in demand for point of care
testing products, rise in the commercial and analytical applications of these
devices, and use of microfluidic products for miniaturization of chip.
Explore Report Description at: https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market
Continuous
innovations in microfluidic devices have led to transformation of drug
discovery and development, gene expression analysis and genotyping in the
pharmaceutical and biopharmaceutical industry. Microfluidic device companies
are entering in collaborations and partnerships to build innovative approaches,
offering advanced tools for diagnostics and research. But regulatory issues act
as hindrance in the development of microfluidic devices market. Apart from
regulatory challenges, the market also confronts issues from surface chemistry
and geometrical problem during manufacturing process.
On
the basis of application, point of care testing (POCT) is by far the fastest
growing application area of microfluidic devices. The growth of application of
microfluidic devices in POCT is expected to witness a CAGR of 28.2% during the
period 2015 to 2020, to reach $1.8 billion in 2020. An increase in point of
care testing, as an effective method for delivery of treatment, has also led to
increase in demand for the microfluidic devices in the global market.
Diagnostic companies are getting access to microfluidic based technologies
through acquisitions, as it reduces the technology development risk and
increases the reactivity.
Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market/report-sampleThe major companies operating in the microfluidic devices market include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cepheid, Dolomite Centre, F. Hoffmann-La Roche, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics, RainDance Technologies, Inc., and Siemens Healthcare, Inc.
No comments:
Post a Comment